Report from the World Health Organization’s immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February–1 March 2024

The Immunization and Vaccine-related Implementation Research Advisory Committee (IVIR-AC) is the World Health Organization’s key standing advisory body to conduct an independent review of research, particularly of transmission and economic modeling analyses that estimate the impact and value of vacc...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2024-05, Vol.42 (15), p.3379-3383
Main Authors: Lambach, Philipp, Silal, Sheetal, Sbarra, Alyssa N., Koh, Mitsuki, Aggarwal, Rakesh, Farooqui, Habib Hasan, Flasche, Stefan, Hogan, Alexandra B., Kim, Sun-Young, Leung, Kathy, Moss, William J., Munywoki, Patrick K., Portnoy, Allison, Sheel, Meru, Wang, Xuan-Yi
Format: Article
Language:English
Subjects:
Advisory Committees
Committees
Cost analysis
Cost-Benefit Analysis
Decision making
Economic analysis
Economic evaluation
Economic models
EPI
Estimates
Humans
Immunization
Immunization - methods
Impact analysis
IVIR-AC
Malaria
Malaria - prevention & control
Malaria Vaccines - administration & dosage
Malaria Vaccines - immunology
Meta-analysis
Modelling
Public health
Teams
Vaccination - methods
Vaccines
Vector-borne diseases
WHO Report
World Health Organization
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Immunization and Vaccine-related Implementation Research Advisory Committee (IVIR-AC) is the World Health Organization’s key standing advisory body to conduct an independent review of research, particularly of transmission and economic modeling analyses that estimate the impact and value of vaccines. From 26th February–1st March 2024, at its first of two semi-annual meetings, IVIR-AC provided feedback and recommendations across four sessions; this report summarizes the proceedings and recommendations from that meeting. Session topics included modeling of the impact and cost-effectiveness of the R21/Matrix-M malaria vaccine, meta-analysis of economic evaluations of vaccines, a global analysis estimating the impact of vaccination over the last 50 years, and modeling the impact of different RTS,S malaria vaccine dose schedules in seasonal settings.
ISSN:0264-410X
1873-2518
1873-2518
DOI:10.1016/j.vaccine.2024.04.057